Capricor Therapeutics (CAPR) vs Evolus (EOLS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Evolus (EOLS) has outperformed Capricor Therapeutics (CAPR) over the past year, gaining 23.6% versus a gain of 8.0%. Over five years, CAPR leads with a +104.5% price change compared with +0.9% for EOLS. Evolus is the larger company by market cap ($511.2 million vs $470.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAPR | EOLS |
|---|---|---|
| Share price | $8.10 | $7.74 |
| Market cap | $470.93M | $511.23M |
| 1-day change | +4.52% | +4.88% |
| YTD return | -71.93% | +16.39% |
| 1-year return | +8.00% | +23.64% |
| 5-year return | +104.55% | +0.91% |
| Forward P/E | — | 26.46 |
| EPS (TTM) | $-2.45 | $-0.53 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $40.37 | $9.31 |
| 52-week low | $2.96 | $3.86 |
| Distance from 52-week high | -79.94% | -16.86% |
| Average volume | 6.83M | 907.37K |
| Shares outstanding | 58.14M | 66.05M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EOLS has outperformed CAPR by 15.6 percentage points over the past year.
CAPR vs EOLS FAQ
Which is bigger, Capricor Therapeutics or Evolus?
Evolus (EOLS) is larger, with a market capitalization of $511.23M compared with $470.93M for Capricor Therapeutics (CAPR).
Which stock has performed better over the past year, CAPR or EOLS?
EOLS returned +23.64% over the past 12 months, compared with +8.00% for CAPR (price return, excluding dividends). Past performance does not predict future results.
Are Capricor Therapeutics and Evolus in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.